Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy

Journal of Leukocyte Biology

Volumn 85, Issue 2, 2009, Pages 235-242

  Lanaro, C ^a   Franco Penteado, C F ^a   Albuqueque, D M ^a   Saad, S T O ^a   Conran, N ^a   Costa, F F ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Chemokines; Gene expression; Heme oxygenase; Mononuclear cell; Neutrophil

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; GAMMA INTERFERON; HEME OXYGENASE; HYDROXYUREA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 8; MESSENGER RNA; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL OCCLUSION; CELL ADHESION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM INJURY; ERYTHROCYTE; FEMALE; GENE EXPRESSION; HEMATOCRIT; HUMAN; INFLAMMATION; LEUKOCYTE; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SICKLE CELL ANEMIA; VASCULAR ENDOTHELIUM;

ADULT; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; HYDROXYUREA; INFLAMMATION MEDIATORS; LEUKOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; RNA, MESSENGER;

EID: 59649100257     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0708445     Document Type: Article

References (51)

1. Chiang, E. Y., Frenette, P. S. (2005) Sickle cell vaso-occlusion. Hematol. Oncol. Clin. North Am. 19, 771-784.
2. Turhan, A., Weiss, L. A., Mohandas, N., Coller, B. S., Frenette, P. S. (2002) Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc. Natl. Acad. Sci. USA 99, 3047-3051.
3. Makis, A. C., Hatzimichael, E. C., Bourantas, K. L. (2000) The role of cytokines in sickle cell disease. Ann. Hematol. 79, 407-413.
4. Hofstra, T. C., Kalra, V. K., Meiselman, H. J., Coates, T. D. (1996) Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst. Blood 87, 4440-4447.
5. Lum, A. F., Wun, T., Staunton, D., Simon, S. I. (2004) Inflammatory potential of neutrophils detected in sickle cell disease. Am. J. Hematol. 76, 126-133.
6. Steinberg, M. H., Lu, Z. H., Barton, F. B., Terrin, M. L., Charache, S., Dover, G. J. (1997) Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. The Multicenter Study of Hydroxyurea. Blood 89, 1078-1088.
7. Kinney, T. R., Helms, R. W., O'Branski, E. E., Ohene-Frempong, K., Wang, W., Daeschner, C., Vichinsky, E., Redding-Lallinger, R., Gee, B., Platt, O. S., Ware, R. E. (1999) Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Blood 94, 1550-1554.
8. Saleh, A. W., Hillen, H. F., Duits, A. J. (1999) Levels of endothelial, neutrophil and platelet-specific factors in sickle cell anemia patients during hydroxyurea therapy. Acta Haematol. 102, 31-37.
9. Charache, S., Barton, F. B., Moore, R. D., Terrin, M. L., Steinberg, M. H., Dover, G. J., Ballas, S. K., McMahon, R. P., Castro, O., Orringer, E. P. (1996) Hydroxyurea and sickle cell anemia. Clinical utility of a myelo-suppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine 75, 300-326.
10. Canalli, A. A., Franco-Penteado, C. F., Traina, F., Saad, S. T., Costa, F. F.,Conran, N. (2007) Role for cAMP-protein kinase A signaling in augmented neutrophil adhesion and chemotaxis in sickle cell disease. Eur. J.Haematol. 79, 330-337.
11. Conran, N., Saad, S. T., Costa, F. F., Ikuta, T. (2007) Leukocyte numbers correlate with plasma levels of granulocyte-macrophage colony-stimulat ing factor in sickle cell disease. Ann. Hematol. 86, 255-261.
12. English, D., Andersen, B. R. (1974) Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J. Immunol. Methods 5, 249-252.
13. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034.
14. Steinberg, M. H. (2006) Pathophysiologically based drug treatment of sickle cell disease. Trends Pharmacol. Sci. 27, 204-210.
15. Tavakkoli, F., Nahavandi, M., Wyche, M. Q., Perlin, E. (2004) Plasma levels of TNF-α in sickle cell patients receiving hydroxyurea. Hematology 9, 61-64.
16. Pathare, A., Al Kindi, S., Alnaqdy, A. A., Daar, S., Knox-Macaulay, H., Dennison, D. (2004) Cytokine profile of sickle cell disease in Oman.Am. J. Hematol. 77, 323-328.
17. Duits, A. J., Schnog, J. B., Lard, L. R., Saleh, A. W., Rojer, R. A. (1998) Elevated IL-8 levels during sickle cell crisis. Eur. J. Haematol. 61,302-305.
18. Goncalves, M. S., Queiroz, I. L., Cardoso, S. A., Zanetti, A., Strapazoni, A. C., Adorno, E., Albuquerque, A., Sant'Ana, A., dos Reis, M. G., Barral, A., Barral Netto, M. (2001) Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease. Braz. J. Med. Biol. Res. 34,1309-1313.
19. Abboud, M. R., Taylor, E. C., Habib, D., Dantzler-Johnson, T., Jackson, S. M., Xu, F., Laver, J., Ballas, S. K. (2000) Elevated serum and bron-choalveolar lavage fluid levels of interleukin 8 and granulocyte colony-stimulating factor associated with the acute chest syndrome in patients with sickle cell disease. Br. J. Haematol. 111, 482-490.
20. Clark, I. A. (2007) How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 18, 335-343.
21. Okamoto, H., Hoshi, D., Kiire, A., Yamanaka, H., Kamatani, N. (2008) Molecular targets of rheumatoid arthritis. Inflamm. Allergy Drug Targets 7, 53-66.
22. Mukaida, N. (2003) Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L566-L577.
23. Mukaida, N. (2000) Interleukin-8: an expanding universe beyond neutro-phil chemotaxis and activation. Int. J. Hematol. 72, 391-398.
24. Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appella, E., Kung, H. F., Leonard, E. J., Oppenheim, J. J. (1988) Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med. 167, 1883-1893.
25. Belcher, J. D., Marker, P. H., Weber, J. P., Hebbel, R. P., Vercellotti, G. M. (2000) Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 96,2451-2459.
26. Wun, T., Cordoba, M., Rangaswami, A., Cheung, A. W., Paglieroni, T. (2002) Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease. Clin. Lab. Haematol. 24, 81-88.
27. Rodrigues, L., Costa, F. F., Saad, S. T., Grotto, H. Z. (2006) High levels of neopterin and interleukin-3 in sickle cell disease patients. J. Clin. Lab.Anal. 20, 75-79.
28. Marcal, L. E., Dias-da-Motta, P. M., Rehder, J., Mamoni, R. L., Blotta, M. H., Whitney, C. B., Newburger, P. E., Costa, F. F., Saad, S. T.,Condino-Neto, A. (2008) Up-regulation of NADPH oxidase components and increased production of interferon-γ by leukocytes from sickle cell disease patients. Am. J. Hematol. 83, 41-45.
29. Schroecksnadel, K., Frick, B., Winkler, C., Fuchs, D. (2006) Crucial role of interferon-γ and stimulated macrophages in cardiovascular disease. Curr. Vasc. Pharmacol. 4, 205-213.
30. Chiang, E. Y., Frenette, P. S. (2005) Sickle cell vaso-occlusion. Hematol Oncol. Clin. North Am. 19, 771-784.
31. Conran, N., Almeida, C. B., Lanaro, C., Ferreira, R. P., Traina, F., Saad, S. T., Costa, F. F. (2007) Inhibition of caspase-dependent spontaneous apoptosis via a cAMP-protein kinase A dependent pathway in neutrophils from sickle cell disease patients. Br. J. Haematol. 139, 148-158.
32. Graido-Gonzalez, E., Doherty, J. C., Bergreen, E. W., Organ, G., Telfer, M., McMillen, M. A. (1998) Plasma endothelin-1, cytokine, and prosta-glandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood 92, 2551-2555.
33. Park, J. Y., Pillinger, M. H., Abramson, S. B. (2006) Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol. 119,229-240.
34. Sugimoto, Y., Narumiya, S. (2007) Prostaglandin E receptors. J. Biol.Chem. 282, 11613-11617.
35. Datta, M. C. (1985) Prostaglandin E2 mediated effects on the synthesis of fetal and adult hemoglobin in blood erythroid bursts. Prostaglandins 29,561-577.
36. Kuroyanagi, Y., Kaneko, Y., Muta, K., Park, B. S., Moi, P., Ausenda, S., Cappellini, M. D., Ikuta, T. (2006) cAMP differentially regulates γ-globin gene expression in erythroleukemic cells and primary erythroblasts through c-Myb expression. Biochem. Biophys. Res. Commun. 344, 1038-1047.
37. Keefer, J. R., Schneidereith, T. A., Mays, A., Purvis, S. H., Dover, G. J., Smith, K. D. (2006) Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells. Exp. Hematol. 34, 1151-1161.
38. Hines, P. C., Zen, Q., Burney, S. N., Shea, D. A., Ataga, K. I., Orringer, E. P., Telen, M. J., Parise, L. V. (2003) Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion. Blood 101, 3281-3287.
39. Tsatsanis, C., Androulidaki, A., Venihaki, M., Margioris, A. N. (2006) Signaling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38, 1654-1661.
40. Kim, S. F., Huri, D. A., Snyder, S. H. (2005) Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310, 1966-1970.
41. Ginnan, R., Guikema, B. J., Halligan, K. E., Singer, H. A., Jourd'heuil, D. (2008) Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic. Biol. Med. 44, 1232-1245.
42. Amer, J., Ghoti, H., Rachmilewitz, E., Koren, A., Levin, C., Fibach, E. (2006) Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br. J. Haematol. 132, 108-113.
43. Hansson, G. K., Geng, Y. J., Holm, J., Hardhammar, P., Wennmalm, A., Jennische, E. (1994) Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J. Exp. Med. 180, 733-738.
44. Otterbein, L. E., Soares, M. P., Yamashita, K., Bach, F. H. (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24, 449-455.
45. Wagener, F. A., Volk, H. D., Willis, D., Abraham, N. G., Soares, M. P.,Adema, G. J., Figdor, C. G. (2003) Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 55, 551-571.
46. Belcher, J. D., Mahaseth, H., Welch, T. E., Otterbein, L. E., Hebbel, R. P., Vercellotti, G. M. (2006) Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J. Clin. Invest. 116,808-816.
47. Jison, M. L., Munson, P. J., Barb, J. J., Suffredini, A. F., Talwar, S., Logun,C., Raghavachari, N., Beigel, J. H., Shelhamer, J. H., Danner, R. L., Gladwin, M. T. (2004) Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood 104, 270-280.
48. Walter, P. B., Fung, E. B., Killilea, D. W., Jiang, Q., Hudes, M., Madden, J., Porter, J., Evans, P., Vichinsky, E., Harmatz, P. (2006) Oxidative stress and inflammation in iron-overloaded patients with β-thalassemia or sickle cell disease. Br. J. Haematol. 135, 254-263.
49. Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P., Mosmann, T. R. (1993) Interleukin-10. Annu. Rev. Immunol. 11, 165-190.
50. Harizi, H., Juzan, M., Pitard, V., Moreau, J. F., Gualde, N. (2002) Cyclooxygenase-2-issued prostaglandin E(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 168, 2255-2263.
51. Couper, K. N., Blount, D. G., Riley, E. M. (2008) IL-10: the master regulator of immunity to infection. J. Immunol. 180, 5771-5777.